Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, ...
Leadership
Carrie L. Bourdow
President, CEO & Chairman
Mark A. Demitrack M.D.
Senior VP & Chief Medical Officer
Howard A. Rockman M.D.Founder
Scientific Founder, Consultant and Member of Scientific Advisory Board
Katrine Sutton
Principal Financial Officer & principal accounting officer
Robert T. Yoder
Senior VP, Chief Business Officer, Head of Commercial Operations & Chief Compliance Officer
